Abbreviated dual antiplatelet therapy after percutaneous coronary intervention using third-generation stents remained ...

Data from the ORBITA-2 randomized, placebo-controlled trial emphasize that patient age alone should not be the deciding ...

Please provide your email address to receive an email when new articles are posted on . Abridged dual therapy followed by direct oral anticoagulant monotherapy after PCI may be safe vs. 1 year of dual ...

With no difference in death or MI, Kevin Bainey says doctors can give medical therapy a good try before sending patients for ...

Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for ...

LONDON, England—Patients with stable coronary artery disease and severe aortic stenosis fare significantly better over the long term if revascularized with PCI before TAVI than if they are treated ...

In the study, which entered people with both AF and recent acute coronary syndromes (ACS) or percutaneous coronary intervention (PCI), all of whom went on a P2Y12 inhibitor, such as clopidogrel, the ...

In addition, the use of standard endoscopy in patients on antiplatelet therapy is limited due to risks such as bleeding. In the OPT-PEACE trial, investigators utilized a non-invasive ...

Phoenix, AZ (May 19, 2023)- New insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor plus aspirin was associated with similar rates of recurrent ...